Transplant Outcomes From Kidney Donors After Extended Times to Circulatory Death

Emily A. Vail,Matthew D. Bacchetta

DOI: https://doi.org/10.1001/jamanetworkopen.2024.43336

2024-11-22

JAMA Network Open

Abstract:In the setting of the increasing use of controlled donation after circulatory death (DCD) to mitigate critical organ shortages around the world, how long should patients, families, clinicians, and recovering transplant teams wait for asystole before a patient is deemed unsuitable for donation? To address this question, Tingle and colleagues 1 examined short- and intermediate-term outcomes of 4102 organ donors after circulatory death and 7183 recipients of kidneys from those donors captured in the United Kingdom organ donor and transplant recipient registry. The investigators examined the association between donors' time to death (from withdrawal of life-sustaining treatment until mechanical asystole) and recipient glomerular filtration rate 1 year after transplant under unique circumstances: a nationally mandated 3-hour minimum observation time after withdrawal (before potential donors are no longer considered eligible to donate). Among the study cohort, most transplanted kidneys were recovered from donors with times to death of less than 30 minutes. Still, the authors estimated that 303 of 6880 transplants (4.4% of the cohort, after imputation) had donor times to death longer than 2 hours, and an additional 885 of 6299 transplants (14.1%) with times between 1 and 2 hours. Regression analyses—accounting for donor and recipient factors associated with recipient kidney function—did not demonstrate an independent association between donor time to death and the primary and secondary recipient outcomes after transplant, leading the investigators to conclude that the policy increases the number of kidneys available for transplant in the UK. Notably, the critical variables negatively associated with recipient outcomes were warm ischemic (asystolic) time, cold ischemic time, and reperfusion time. These factors are independent of the time to death, suggesting that improving transplant logistics and technical issues could further mitigate graft dysfunction. Recognizing that the study was limited by factors inherent to analyses of preexisting data, investigators used multiple imputation and other strategies to address some concerns. More fundamentally, registry data only captured the group of successful donors and their ultimately transplanted kidneys; clinical factors (such as hypoxemia and medication administration during the withdrawal period) and critical outcomes, including aborted donation attempts and kidney discards, could not be ascertained. Thus, the study used organ transplant as a proxy outcome for the central but currently unanswerable question of acceptable graft quality from donors with prolonged times to death. Despite this gap, some findings (such as younger donor ages, higher rates of normothermic regional perfusion use, and lower rates of observed tissue patchiness on reperfusion among kidneys recovered from donors with extended times to death) suggest that transplant programs may evaluate and select organs differently across the spectrum of observations. In the setting of these limitations, the study ultimately asks a different (but incrementally important) question: Among transplanted kidneys from DCD donors in the UK, is the duration of time to death after withdrawal associated with recipient glomerular filtration rate at 1 year? Along with concerns that findings may not be generalizable to other organ donation and transplantation systems with differences in donation rates, organ allocation policies, and acceptable transplant outcomes, this means that the study cannot be interpreted as practice changing. However, it builds on evidence of ongoing changes among transplant programs and US organ procurement organizations, whose estimated median minimum wait times (in 2017) were 90 minutes. 2 While individual donor hospital policies may further modify regional wait times, and surgeons' real-time concerns about perceived futility or graft quality may lead to late kidney discard, in an era in which donor eligibility, 3 clinical donor management, 4 organ assessment, 5 and organ storage and preservation 6 are actively reconsidered, donor time to death is another factor worthy of reexamination. While it is plausible that kidneys with adequate perfusion throughout the withdrawal period (of any duration) function normally after death and organ recovery, there remain unmet needs for bedside tools to reveal the degree of sustained tissue damage across the period of withdrawal and recovery and for interventions that specifically target this potentially modifiable harm. In the short term, we recognize that an extended observation period may be variably acceptable to patients and families and may have unforeseen consequences for the quality and utilization of other donated organs. Furthermore, extended times require additional health care resources (including the presence of a bedside clinician, periopera -Abstract Truncated-

medicine, general & internal